# Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism

> **NCT00643201** · PHASE3 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 5614 (actual)

## Conditions studied

- Venous Thrombosis

## Interventions

- **DRUG:** Enoxaparin
- **DRUG:** warfarin
- **DRUG:** Placebo for apixaban
- **DRUG:** Placebo for enoxaparin
- **DRUG:** Placebo for warfarin
- **DRUG:** apixaban

## Key facts

- **NCT ID:** NCT00643201
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 5614 (ACTUAL)
- **Last updated:** 2014-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00643201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00643201, "Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00643201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*